226 related articles for article (PubMed ID: 9696885)
1. Relationships between the structure and the roles of lipoarabinomannans and related glycoconjugates in tuberculosis pathogenesis.
Vercellone A; Nigou J; Puzo G
Front Biosci; 1998 Aug; 3():e149-63. PubMed ID: 9696885
[TBL] [Abstract][Full Text] [Related]
2. New structural insights into the molecular deciphering of mycobacterial lipoglycan binding to C-type lectins: lipoarabinomannan glycoform characterization and quantification by capillary electrophoresis at the subnanomole level.
Nigou J; Vercellone A; Puzo G
J Mol Biol; 2000 Jun; 299(5):1353-62. PubMed ID: 10873458
[TBL] [Abstract][Full Text] [Related]
3. Lipoarabinomannans: from structure to biosynthesis.
Nigou J; Gilleron M; Puzo G
Biochimie; 2003; 85(1-2):153-66. PubMed ID: 12765785
[TBL] [Abstract][Full Text] [Related]
4. Mycobacterial lipoarabinomannan and related lipoglycans: from biogenesis to modulation of the immune response.
Briken V; Porcelli SA; Besra GS; Kremer L
Mol Microbiol; 2004 Jul; 53(2):391-403. PubMed ID: 15228522
[TBL] [Abstract][Full Text] [Related]
5. Lipoarabinomannan, and its related glycolipids, induce divergent and opposing immune responses to Mycobacterium tuberculosis depending on structural diversity and experimental variations.
Källenius G; Correia-Neves M; Buteme H; Hamasur B; Svenson SB
Tuberculosis (Edinb); 2016 Jan; 96():120-30. PubMed ID: 26586646
[TBL] [Abstract][Full Text] [Related]
6. Mycobacterial lipoarabinomannans: modulators of dendritic cell function and the apoptotic response.
Nigou J; Gilleron M; Rojas M; García LF; Thurnher M; Puzo G
Microbes Infect; 2002 Jul; 4(9):945-53. PubMed ID: 12106787
[TBL] [Abstract][Full Text] [Related]
7. Roles of lipoarabinomannan in the pathogenesis of tuberculosis.
Strohmeier GR; Fenton MJ
Microbes Infect; 1999 Jul; 1(9):709-17. PubMed ID: 10611748
[TBL] [Abstract][Full Text] [Related]
8. Structural analysis of mycobacterial lipoglycans.
Nigou J; Gilleron M; Brando T; Puzo G
Appl Biochem Biotechnol; 2004; 118(1-3):253-67. PubMed ID: 15304754
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of Mycobacterium tuberculosis manB, a phosphomannomutase that increases phosphatidylinositol mannoside biosynthesis in Mycobacterium smegmatis and mycobacterial association with human macrophages.
McCarthy TR; Torrelles JB; MacFarlane AS; Katawczik M; Kutzbach B; Desjardin LE; Clegg S; Goldberg JB; Schlesinger LS
Mol Microbiol; 2005 Nov; 58(3):774-90. PubMed ID: 16238626
[TBL] [Abstract][Full Text] [Related]
10. Mannosylated structures of mycobacterial lipoarabinomannans facilitate the maturation and activation of dendritic cells.
Zhang S; Wu Q; Lei H; Zheng H; Zhou F; Sun Z; Zhao J; Yu X; Zhang S
Cell Immunol; 2019 Jan; 335():85-92. PubMed ID: 30527747
[TBL] [Abstract][Full Text] [Related]
11. Lipoglycans are putative ligands for the human pulmonary surfactant protein A attachment to mycobacteria. Critical role of the lipids for lectin-carbohydrate recognition.
Sidobre S; Nigou J; Puzo G; Rivière M
J Biol Chem; 2000 Jan; 275(4):2415-22. PubMed ID: 10644694
[TBL] [Abstract][Full Text] [Related]
12. Mycobacterium tuberculosis lipomannan induces apoptosis and interleukin-12 production in macrophages.
Dao DN; Kremer L; Guérardel Y; Molano A; Jacobs WR; Porcelli SA; Briken V
Infect Immun; 2004 Apr; 72(4):2067-74. PubMed ID: 15039328
[TBL] [Abstract][Full Text] [Related]
13. Lipoarabinomannans derived from different strains of Mycobacterium tuberculosis differentially stimulate the activation of NF-kappa B and KBF1 in murine macrophages.
Brown MC; Taffet SM
Infect Immun; 1995 May; 63(5):1960-8. PubMed ID: 7729908
[TBL] [Abstract][Full Text] [Related]
14. Inactivation of Mycobacterium tuberculosis mannosyltransferase pimB reduces the cell wall lipoarabinomannan and lipomannan content and increases the rate of bacterial-induced human macrophage cell death.
Torrelles JB; DesJardin LE; MacNeil J; Kaufman TM; Kutzbach B; Knaup R; McCarthy TR; Gurcha SS; Besra GS; Clegg S; Schlesinger LS
Glycobiology; 2009 Jul; 19(7):743-55. PubMed ID: 19318518
[TBL] [Abstract][Full Text] [Related]
15. The Impact of Genome Region of Difference 4 (RD4) on Mycobacterial Virulence and BCG Efficacy.
Ru H; Liu X; Lin C; Yang J; Chen F; Sun R; Zhang L; Liu J
Front Cell Infect Microbiol; 2017; 7():239. PubMed ID: 28642843
[TBL] [Abstract][Full Text] [Related]
16. Critical roles for lipomannan and lipoarabinomannan in cell wall integrity of mycobacteria and pathogenesis of tuberculosis.
Fukuda T; Matsumura T; Ato M; Hamasaki M; Nishiuchi Y; Murakami Y; Maeda Y; Yoshimori T; Matsumoto S; Kobayashi K; Kinoshita T; Morita YS
mBio; 2013 Feb; 4(1):e00472-12. PubMed ID: 23422411
[TBL] [Abstract][Full Text] [Related]
17. The Phosphatidyl-
Boldrin F; Anso I; Alebouyeh S; Sevilla IA; Geijo M; Garrido JM; Marina A; Cioetto Mazzabò L; Segafreddo G; Guerin ME; Manganelli R; Prados-Rosales R
J Bacteriol; 2021 Mar; 203(7):. PubMed ID: 33468587
[No Abstract] [Full Text] [Related]
18. Differential expression of mycobacterial proteins following phagocytosis by macrophages.
Monahan IM; Betts J; Banerjee DK; Butcher PD
Microbiology (Reading); 2001 Feb; 147(Pt 2):459-471. PubMed ID: 11158363
[TBL] [Abstract][Full Text] [Related]
19. Structural differences in lipomannans from pathogenic and nonpathogenic mycobacteria that impact CD1b-restricted T cell responses.
Torrelles JB; Sieling PA; Arcos J; Knaup R; Bartling C; Rajaram MVS; Stenger S; Modlin RL; Schlesinger LS
J Biol Chem; 2011 Oct; 286(41):35438-35446. PubMed ID: 21859718
[TBL] [Abstract][Full Text] [Related]
20. Mycobacterial virulence. Virulent strains of Mycobacteria tuberculosis have faster in vivo doubling times and are better equipped to resist growth-inhibiting functions of macrophages in the presence and absence of specific immunity.
North RJ; Izzo AA
J Exp Med; 1993 Jun; 177(6):1723-33. PubMed ID: 8496688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
